SHIONOGI Canadian Trademark Information

On Tuesday, September 1, 2009, a canadian trademark registration was filed for SHIONOGI by SHIONOGI & CO., LTD. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1450811. The current status of this trademark filing is Registration published. The SHIONOGI trademark is filed in the description of Pharmaceutical preparations, namely, antibiotics, antivirals, antiparasites, anti-epilepsia, antifebrile, acesodyne, anti-Parkinson disease, hypnotic agents, sedatives, antidepressants, antipsychotic, allergy medication, anti-inflammatories, antihistamines, hormonal preparations, antihypertensives, fever, cold, cough treatment, emulgent, vitamin preparation; pharmaceutical preparations for the prevention and/or treatment of metabolic diseases and disorders, namely, insulin resistance, metabolic syndrome, hyperlipidemia, and diabetes mellitus; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for treating women’s health, namely, birth control preparations, prenatal vitamins, hormones and menstrual pain relief medications; pharmaceutical preparations for use in pediatrics, namely, for treating allergic states, dermatologic diseases, edematous states, endocrine disorders, hematologic disorders, neoplastic diseases; pharmaceutical preparations for use in ophthalmology. , Pharmaceutical preparations, namely, antibiotics, antivirals, antiparasites, anti-epilepsia, antifebrile, acesodyne, anti-Parkinson disease, hypnotic agents, sedatives, antidepressants, antipsychotic, allergy medication, anti-inflammatories, antihistamines, hormonal preparations, antihypertensives, fever, cold, cough treatment, emulgent, vitamin preparation; pharmaceutical preparations for the prevention and/or treatment of metabolic diseases and disorders, namely, insulin resistance, metabolic syndrome, hyperlipidemia, and diabetes mellitus; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for treating women’s health, namely, birth control preparations, prenatal vitamins, hormones and menstrual pain relief medications; pharmaceutical preparations for use in pediatrics, namely, for treating allergic states, dermatologic diseases, edematous states, endocrine disorders, hematologic disorders, neoplastic diseases; pharmaceutical preparations for use in ophthalmology. .